LGND (LGND) Stock Price & Analysis
LGND (LGND) fell 1.43% to USD 285.6 as of September 8, 2026 at 05:01 UTC, according to Nexqual real-time market data.
LGND last closed at USD 285.6; the session ranged USD 285.47–289.72 on volume of 132,389 shares. Market capitalization is —, with a 52-week range of USD 161.82–326.63 (NGM). Source: Nexqual, September 8, 2026 at 05:01 UTC.
Key Statistics (as of September 8, 2026 at 05:01 UTC)
| Price | USD 285.6 |
|---|---|
| Change | ▼ 1.43% (down) |
| Previous Close | USD 285.6 |
| Open | USD 285.6 |
| Day Range | USD 285.47 – 289.72 |
| 52-Week Range | USD 161.82 – 326.63 |
| Volume | 132,389 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (LGND)
Nexqual's technical model rates LGND "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 05:01 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.51 (neutral) |
| vs SMA50 | Below (USD 297.52) |
| MACD | -1.98 (negative) |
From LGND's Latest SEC 10-K Filing (filed 2026-02-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NBIX | Neurocrine Biosciences, Inc. | USD 155.64 | ▼ 1.36% |
| INCY | Incyte Corporation | USD 126.75 | ▼ 1.61% |
| ALKS | Alkermes plc | USD 46.1 | ▼ 3.39% |
| MYGN | Myriad Genetics, Inc. | USD 3.19 | ▼ 1.24% |
| UTHR | United Therapeutics Corporation | USD 487.61 | ▼ 0.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:01 UTC. This page is informational and not investment advice.